244
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Pharmacogenetics‐Based New Therapeutic Concepts

, , , , , , , , , & show all
Pages 617-638 | Published online: 25 Oct 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Sandro Salamone, Sara Spirito, Maurizio Simmaco, Marius Unger, Saskia Preissner, Björn-Oliver Gohlke, Andreas Eckert & Robert Preissner. (2022) Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy. Pharmacogenomics and Personalized Medicine 15, pages 765-773.
Read now
K. A. Nielsen, E. Lyders Hansen & S. Gille. (2007) Genotyping of the cytochrome P450 2D6 4469 C>T polymorphism using SimpleProbes™. Scandinavian Journal of Clinical and Laboratory Investigation 67:3, pages 280-290.
Read now
Cheri M Turman, Jade M Hatley, Daniel J Ryder, Vijayalakshmi Ravindranath & Henry W Strobel. (2006) Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: the convolution continues. Expert Opinion on Drug Metabolism & Toxicology 2:3, pages 399-418.
Read now
J. O. Rasmussen, M. Christensen, J. M. Svendsen, O. Skausig, E. L. Hansen & K. A. Nielsen. (2006) CYP2D6 gene test in psychiatric patients and healthy volunteers. Scandinavian Journal of Clinical and Laboratory Investigation 66:2, pages 129-136.
Read now
Alfred G. Hildebrandt. (2004) Pharmacology, Drug Efficacy, and the Individual . Drug Metabolism Reviews 36:3-4, pages 845-852.
Read now

Articles from other publishers (23)

Go-Wun Choi, Yong-Bok Lee & Hea-Young Cho. (2019) Interpretation of Non-Clinical Data for Prediction of Human Pharmacokinetic Parameters: In Vitro-In Vivo Extrapolation and Allometric Scaling. Pharmaceutics 11:4, pages 168.
Crossref
Laura B. Ramsey, Cynthia A. Prows, Kejian Zhang, Shannon N. Saldaña, Michael T. Sorter, John P. Pestian, Richard J. Wenstrup, Alexander A. Vinks & Tracy A. Glauser. (2018) Implementation of Pharmacogenetics at Cincinnati Children's Hospital Medical Center: Lessons Learned Over 14 Years of Personalizing Medicine. Clinical Pharmacology & Therapeutics 105:1, pages 49-52.
Crossref
. 2014. Essential Oil Safety. Essential Oil Safety 677 755 .
Robert Tisserand & Rodney Young. 2014. Essential Oil Safety. Essential Oil Safety 39 67 .
Anupam Shukla, Ritu Tiwari & Chandra Prakash Rathore. 2011. Biomedical Engineering and Information Systems. Biomedical Engineering and Information Systems 259 276 .
Michael Murray. (2006) Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents. Journal of Pharmacy and Pharmacology 58:7, pages 871-885.
Crossref
Vural Ozdemir, Janice E. Graham & Béatrice Godard. (2008) Race as a variable in pharmacogenomics science: from empirical ethics to publication standards. Pharmacogenetics and Genomics 18:10, pages 837-841.
Crossref
Galo Peralta, María Blanca Sánchez, Santiago Echevarría, Elsa María Valdizán & Juan Antonio Armijo. (2008) Glucoproteína P e infección por el virus de la inmunodeficiencia humana. Enfermedades Infecciosas y Microbiología Clínica 26:3, pages 150-159.
Crossref
Diana Klanovicz Silva & Fabiana Michelsen de Andrade. (2008) Farmacogenética de inibidores seletivos de recaptação de serotonina: uma revisão. Revista de Psiquiatria do Rio Grande do Sul 30:1 suppl.
Crossref
Ivar Roots, Gabriele Laschinski & Urs A. Meyer. 2008. Grundlagen der Molekularen Medizin. Grundlagen der Molekularen Medizin 314 331 .
A D Roses, A M Saunders, Y Huang, J Strum, K H Weisgraber & R W Mahley. (2006) Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease). The Pharmacogenomics Journal 7:1, pages 10-28.
Crossref
Xing Jian Lou, Russ B. Altman & Teri E. Klein. 2007. Bioinformatics‐From Genomes to Therapies. Bioinformatics‐From Genomes to Therapies 1427 1455 .
I. Roots, G. Laschinski, F. Arjomand-Nahad, J. Kirchheiner, D. Schwarz, J. Brockmöller, I. Cascorbi & T. Gerloff. 2007. Appropriate Dose Selection — How to Optimize Clinical Drug Development. Appropriate Dose Selection — How to Optimize Clinical Drug Development 81 100 .
Christian Meisel & Ivar Roots. 2007. Medizinische Therapie 2007 | 2008. Medizinische Therapie 2007 | 2008 13 18 .
Edeltraut Garbe & Frank Andersohn. (2006) Contraindication labelling changes in the United States and Germany. European Journal of Clinical Pharmacology 63:1, pages 87-93.
Crossref
M. Mousny, X. Banse, L. Wise, E.T. Everett, R. Hancock, R. Vieth, J.P. Devogelaer & M.D. Grynpas. (2006) The genetic influence on bone susceptibility to fluoride. Bone 39:6, pages 1283-1289.
Crossref
Rashmi R Shah. (2006) Can pharmacogenetics help rescue drugs withdrawn from the market?. Pharmacogenomics 7:6, pages 889-908.
Crossref
Sara Padol, Yuhong Yuan, Marroon Thabane, Ireneusz T Padol & Richard H Hunt. (2006) The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis. The American Journal of Gastroenterology 101:7, pages 1467-1475.
Crossref
Ch. Meisel & I. Roots. 2006. Praktische Arzneitherapie. Praktische Arzneitherapie 103 109 .
Kewal K. Jain. (2012) Applications of AmpliChip™ CYP450. Molecular Diagnosis 9:3, pages 119-127.
Crossref
Arnold E. Ruoho. (2005) How the Monoamine Transporter Garden Grows: Fig. 1.. Molecular Pharmacology 68:2, pages 272-274.
Crossref
Barkur S. Shastry. (2005) Genetic diversity and new therapeutic concepts. Journal of Human Genetics 50:7, pages 321-328.
Crossref
Kewal K Jain. (2005) Applications of AmpliChip??? CYP450. Molecular Diagnosis 9:3, pages 119-127.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.